Brief: Titan Medical Announces Commencement Of Strategic Review Process
30/11/2022 12:34
Nov 30 (Reuters) - Titan Medical Inc TMD.TO :
* TITAN MEDICAL ANNOUNCES COMMENCEMENT OF STRATEGIC REVIEW
PROCESS
* TITAN MEDICAL - BOARD TO CONSIDER FULL RANGE OF STRATEGIC
ALTERNATIVES INCLUDING CORPORATE SALE, MERGER, OTHER BUSINESS
COMBINATION
* TITAN MEDICAL INC - AS PART OF STRATEGIC REVIEW PROCESS,
COMPANY
HAS ENGAGED RAYMOND JAMES AS FINANCIAL ADVISOR
* TITAN MEDICAL INC - HAS NOT SET A TIMETABLE FOR COMPLETION
OF
PROCESS
* TITAN MEDICAL INC - THERE CAN BE NO ASSURANCE THAT
STRATEGIC
REVIEW PROCESS WILL RESULT IN ANY TRANSACTION
* TITAN MEDICAL INC - BOARD WILL CONSIDER SALE OF ALL OR A
PORTION
OF COMPANY'S ASSETS, STRATEGIC INVESTMENT OR OTHER SIGNIFICANT
TRANSACTION
Source text for Eikon: ID:nGNXlNbHG
Further company coverage: TMD.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Conavi Medical
See all newsBrief: Conavi Medical Announces Pricing Of Public Offering Of Common Shares
Brief: Conavi Medical Announces Agreement With The Province Of Ontario As Part Of The Life Sciences Scale-Up Fund
Brief: Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System To Us FDA For 510(K) Clearance
Brief: Conavi Medical Corp. Announces Closing Of $20M Public Offering
Brief: Titan Medical Says To Delist From Tsx & Apply To Re-List On TSX Venture Exchange